Recruitment Status

Completed clinical trials

Status pages show live ClinicalTrials.gov search results by recruitment status, with direct links to official study records plus page-level filtering and sorting.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 6:32 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

121318

Shown on this page

Current sort

Live official records

Open in full search

Conditions: Drug-induced Weight Gain
Interventions: RDX-002 + Olanzipine, Olanzapine; Drug
Lead sponsor: Response Pharmaceuticals; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: MASLD, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), NAFLD, NAFLD (Nonalcoholic Fatty Liver Disease)
Interventions: LiverScope® exam, MR exam, Blood draw, Body measurements, Questionnaire; Diagnostic Test · Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Cerebro-vascular Accident, Exercise, Blood Flow Restriction (BFR) Training Effects
Interventions: BFR; Behavioral
Lead sponsor: Saint Joseph's University, Philadelphia; Other
Eligibility: 21 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Frailty
Interventions: High Intensity Walking, Casual Speed Walking; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 60 Years and older
Enrollment: 165 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Multiple Myeloma and Plasma Cell Neoplasm, Neurotoxicity
Interventions: bortezomib, dexamethasone, melphalan, thalidomide, cytogenetic analysis, fluorescence in situ hybridization, laboratory biomarker analysis, questionnaire administration, autologous hematopoietic stem cell transplantation, peripheral blood stem cell transplantation; Drug · Genetic · Other + 1 more
Lead sponsor: City of Hope Medical Center; Other
Eligibility: Up to 70 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Duarte, California

Conditions: Healthy
Interventions: MK-4082, Diltiazem, Rescue medication; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Anaheim, California

Conditions: Incisional Ventral Hernia
Interventions: Not applicable- observational study; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Psychological Distress, Psychological Trauma, Historical, Nutrition
Interventions: Not listed
Lead sponsor: True Paleo Inc.; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Chronic Pain
Interventions: Group Acupuncture Intervention; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Mebane, North Carolina

Conditions: Clear Cell Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Metastatic
Interventions: Selenomethionine (SLM), Axitinib, Pembrolizumab; Drug
Lead sponsor: Fernando Maciel Barbosa; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Non-small Cell Lung Cancer (NSCLC)
Interventions: Nivolumab + ipilimumab, Nivolumab + ipilimumab + platinum-based chemotherapy, Immuno-oncology-based therapy (excluding nivolumab-based regimens) with chemotherapy, Other dual-immuno-oncology therapy with chemotherapy; Biological
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Fleming Island, Florida

Conditions: Nasal Airway Obstruction
Interventions: Not listed
Lead sponsor: Aerin Medical; Industry
Eligibility: 22 Years to 85 Years
Enrollment: 1,110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Completed clinical trials

Filter and sort this status page

Live official records

Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine

Accurate Point of Care Liver Disease Diagnostics (Phase 2)

Supplemental Blood Flow Restriction Training to Improve the Upper Extremity in Chronic Stroke

The Effect of Walking on Frailty

Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)

Cytokine Response to Abdominal Wall Reconstruction

Homeless Lifestyle Community Survey

Group Acupuncture for Pain

Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab

Long-Term Safety Outcomes and First-Line Treatment Patterns in Patients With Non-Small Cell Lung Cancer and Programmed Death-1 (Pd-L1) <1%

An Ambispective Registry Study Comparing Clinical Outcomes of Surgical Interventions for the Treatment of Nasal Airway Obstruction.